CIBMTR Reporting Implementation Guide
0.1.8 - Trial Use 1
This page is part of the CIBMTR Reporting Implementation Guide (v0.1.8: Release Draft) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version. For a full list of available versions, see the Directory of published versions
{
"resourceType" : "Medication",
"id" : "Medication-Post-HCT-Disease-Therapy-Example",
"meta" : {
"profile" : [
🔗 "http://fhir.nmdp.org/ig/cibmtr-reporting/StructureDefinition/cibmtr-post-hct-disease-therapy-planned-medication"
],
"security" : [
{
"system" : "http://terminology.cibmtr.org/codesystem/transplant-center",
"code" : "rc_99999",
"display" : "99999 My Transplant Center"
}
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: Medication Medication-Post-HCT-Disease-Therapy-Example</b></p><a name=\"Medication-Post-HCT-Disease-Therapy-Example\"> </a><a name=\"hcMedication-Post-HCT-Disease-Therapy-Example\"> </a><a name=\"Medication-Post-HCT-Disease-Therapy-Example-en-US\"> </a><p><b>code</b>: <span title=\"Codes:{http://www.nlm.nih.gov/research/umls/rxnorm 1597258}, {http://www.nlm.nih.gov/research/umls/rxnorm 1597260}, {http://www.nlm.nih.gov/research/umls/rxnorm 1597262}, {http://www.nlm.nih.gov/research/umls/rxnorm 1597267}, {http://www.nlm.nih.gov/research/umls/rxnorm 1651249}, {http://www.nlm.nih.gov/research/umls/rxnorm 1651250}, {http://www.nlm.nih.gov/research/umls/rxnorm 1651252}, {http://www.nlm.nih.gov/research/umls/rxnorm 1651253}\">blinatumomab</span></p><h3>Ingredients</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Item[x]</b></td><td><b>Strength</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{http://www.nlm.nih.gov/research/umls/rxnorm 1597258}, {http://www.nlm.nih.gov/research/umls/rxnorm 1597260}, {http://www.nlm.nih.gov/research/umls/rxnorm 1597262}, {http://www.nlm.nih.gov/research/umls/rxnorm 1597267}, {http://www.nlm.nih.gov/research/umls/rxnorm 1651249}, {http://www.nlm.nih.gov/research/umls/rxnorm 1651250}, {http://www.nlm.nih.gov/research/umls/rxnorm 1651252}, {http://www.nlm.nih.gov/research/umls/rxnorm 1651253}\">blinatumomab</span></td><td>0.035 milligram<span style=\"background: LightGoldenRodYellow\"> (Details: UCUM codemg = 'mg')</span>/0.035 milligram<span style=\"background: LightGoldenRodYellow\"> (Details: UCUM codemg = 'mg')</span></td></tr></table></div>"
},
"code" : {
"coding" : [
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "1597258",
"display" : "blinatumomab"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "1597260",
"display" : "blinatumomab Injectable Product"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "1597262",
"display" : "blinatumomab 0.035 MG Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "1597267",
"display" : "blinatumomab 0.035 MG Injection [Blincyto]"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "1651249",
"display" : "blinatumomab 0.035 MG"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "1651250",
"display" : "blinatumomab Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "1651252",
"display" : "blinatumomab 0.035 MG [Blincyto]"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "1651253",
"display" : "blinatumomab Injection [Blincyto]"
}
],
"text" : "blinatumomab"
},
"ingredient" : [
{
"itemCodeableConcept" : {
"coding" : [
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "1597258",
"display" : "blinatumomab"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "1597260",
"display" : "blinatumomab Injectable Product"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "1597262",
"display" : "blinatumomab 0.035 MG Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "1597267",
"display" : "blinatumomab 0.035 MG Injection [Blincyto]"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "1651249",
"display" : "blinatumomab 0.035 MG"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "1651250",
"display" : "blinatumomab Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "1651252",
"display" : "blinatumomab 0.035 MG [Blincyto]"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "1651253",
"display" : "blinatumomab Injection [Blincyto]"
}
],
"text" : "blinatumomab"
},
"strength" : {
"numerator" : {
"value" : 0.035,
"unit" : "milligram",
"system" : "http://unitsofmeasure.org",
"code" : "mg"
},
"denominator" : {
"value" : 0.035,
"unit" : "milligram",
"system" : "http://unitsofmeasure.org",
"code" : "mg"
}
}
}
]
}